Video

Dr. Stadtmauer on Current Challenges With Multiple Myeloma

Edward A. Stadtmauer, MD, section chief of Hematologic Malignancies, Abramson Cancer Center, University of Pennsylvania, discusses the current challenges with multiple myeloma.

The biggest challenge with multiple myeloma is understanding which combinations or sequences to use with these field-changing agents, explains Stadtmauer.

Ongoing trials are helping oncologists understand more about when and how long to treat patients with these agents. Stadtmauer says he is hopeful about the outcome for patients with multiple myeloma.

Related Videos
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Tiago Biachi, MD, PhD
Dr Girard on De Novo and Acquired Resistance Alterations in HER2-Altered NSCLC
Elias Jabbour, MD
Daniel DeAngelo, MD, PhD
Douglas W. Sborov, MD, MS